Pharma Stability: Insights, Guidelines, and Expertise
SOP for Designing Stability Studies for Combination Products as per Regulatory Guidelines Guidelines for Stability Studies of Combination Products 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the process for designing stability studies for combination products in accordance with relevant regulatory guidelines. This SOP ensures that stability studies provide adequate…
SOP for Implementing ICH Q1E for Stability Data Evaluation Guidelines for Stability Data Evaluation as per ICH Q1E 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the process for evaluating stability data of drug substances and products in accordance with the ICH Q1E guidelines. This SOP ensures consistent and scientifically…
Read More “SOP for Implementing ICH Q1E for Stability Data Evaluation” »
SOP for Conducting Stability Studies for Drug Substances Under US FDA Guidelines Guidelines for Stability Testing of Drug Substances as per US FDA 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to define the procedure for conducting stability studies for drug substances in accordance with US FDA guidelines. This SOP ensures that…
Read More “SOP for Conducting Stability Studies for Drug Substances Under US FDA Guidelines” »
SOP for Developing a Stability-Indicating Method in Compliance with ICH Q2(R1) Guidelines for Creating Stability-Indicating Methods as per ICH Q2(R1) 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the process for developing and validating a stability-indicating method for drug substances and drug products in accordance with the ICH Q2(R1) guidelines….
Read More “SOP for Developing a Stability-Indicating Method in Compliance with ICH Q2(R1)” »
SOP for Addressing Stability Issues in ANDA Submissions to the US FDA Guidelines for Managing Stability Issues in ANDA Submissions 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to provide guidance on identifying, investigating, and resolving stability issues in Abbreviated New Drug Application (ANDA) submissions to the United States Food and Drug…
Read More “SOP for Addressing Stability Issues in ANDA Submissions to the US FDA” »
SOP for Conducting Stability Studies for Biologics Following FDA Guidelines Guidelines for Stability Testing of Biologics as per FDA Guidelines 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to define the process for conducting stability studies for biological drug substances and products in accordance with the US FDA guidelines. This SOP aims…
Read More “SOP for Conducting Stability Studies for Biologics Following FDA Guidelines” »
SOP for Implementing Stability Studies for Drug Products in Compliance with US FDA CFR Title 21 Guidelines for Stability Studies as per US FDA CFR Title 21 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the procedure for conducting stability studies of drug products in compliance with the US FDA…
Mitigating Risks of False Shelf Life Predictions in Accelerated Studies How to Avoid False Shelf Life Predictions in Accelerated Stability Studies Accelerated stability testing offers pharmaceutical developers a time-saving method for estimating shelf life. However, relying solely on accelerated data poses the risk of inaccurate predictions. Misinterpretation of degradation trends, variability in conditions, or inappropriate…
Read More “Mitigating Risks of False Shelf Life Predictions in Accelerated Studies” »
SOP for Preparing a Stability Protocol in Accordance with ICH Q1A(R2) Guidelines for Developing a Stability Protocol as per ICH Q1A(R2) 1) Purpose The purpose of this Standard Operating Procedure (SOP) is to outline the procedure for preparing a stability protocol for drug substances and drug products in compliance with the ICH Q1A(R2) guidelines. This…
Read More “SOP for Preparing a Stability Protocol in Accordance with ICH Q1A(R2)” »
Temperature and Humidity Impact on Accelerated Stability Testing How Temperature and Humidity Affect Accelerated Stability Testing in Pharma Accelerated stability testing simulates long-term drug product degradation by exposing samples to elevated temperature and humidity. These environmental factors directly influence the degradation rate and physical integrity of pharmaceuticals. This guide explores the impact of temperature and…
Read More “Temperature and Humidity Impact on Accelerated Stability Testing” »
Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.